Home › Idiopathic Pulmonary Fibrosis › Utah
Idiopathic Pulmonary Fibrosis clinical trials in Utah
5 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Utah.
Cities in Utah
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Intermountain Medical Center, Murray
- University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cedar Clinical Research Inc., Draper
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Utah, Salt Lake City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Utah, Salt Lake City
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Salt Lake City, UT, Salt Lake City
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.